ID   MLH1_YEAST              Reviewed;         769 AA.
AC   P38920; D6VZY9; Q2I028; Q2I029; Q2I031; Q2I032; Q2I033; Q2I034;
AC   Q2I035; Q2I036; Q2I038; Q2I039; Q2I041;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-JUL-2015, entry version 148.
DE   RecName: Full=DNA mismatch repair protein MLH1;
DE   AltName: Full=MutL protein homolog 1;
DE   AltName: Full=Post meiotic segregation protein 2;
GN   Name=MLH1; Synonyms=PMS2; OrderedLocusNames=YMR167W;
GN   ORFNames=YM8520.16;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8264608;
RA   Prolla T.A., Christie D.-M., Liskay R.M.;
RT   "Dual requirement in yeast DNA mismatch repair for MLH1 and PMS1, two
RT   homologs of the bacterial mutL gene.";
RL   Mol. Cell. Biol. 14:407-415(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-240; GLU-242;
RP   PRO-271; LEU-309; ASP-321; LYS-333; THR-375; GLY-452; ASN-465;
RP   SER-470; PHE-607; ASN-678; LEU-703 AND GLY-761.
RC   STRAIN=ATCC 200060 / W303, EAY1066, EAY1068, M2-8, M5-7, M7-8, SK1,
RC   YJM 145, YJM 269, YJM 280, YJM 320, YJM 326, YJM 339, and YJM 627;
RX   PubMed=16492773; DOI=10.1073/pnas.0510998103;
RA   Heck J.A., Argueso J.L., Gemici Z., Reeves R.G., Bernard A.,
RA   Aquadro C.F., Alani E.;
RT   "Negative epistasis between natural variants of the Saccharomyces
RT   cerevisiae MLH1 and PMS1 genes results in a defect in mismatch
RT   repair.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:3256-3261(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S.,
RA   Jagels K., Lye G., Moule S., Odell C., Pearson D., Rajandream M.A.,
RA   Rice P., Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   XIII.";
RL   Nature 387:90-93(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   MUTAGENESIS OF ALA-41; GLY-64; ILE-65; GLU-99; ILE-104; THR-114;
RP   ARG-214; VAL-216; ARG-265; ILE-326; GLN-552; ARG-672 AND ALA-694.
RX   PubMed=11555625; DOI=10.1093/hmg/10.18.1889;
RA   Ellison A.R., Lofing J., Bitter G.A.;
RT   "Functional analysis of human MLH1 and MSH2 missense variants and
RT   hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae.";
RL   Hum. Mol. Genet. 10:1889-1900(2001).
RN   [6]
RP   INTERACTION WITH PMS1, AND MUTAGENESIS OF ALA-41; PHE-96; ARG-97;
RP   GLY-98; LYS-764; PHE-766; GLU-767 AND CYS-769.
RX   PubMed=9234704;
RA   Pang Q., Prolla T.A., Liskay R.M.;
RT   "Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p
RT   DNA mismatch repair proteins and their relevance to human hereditary
RT   nonpolyposis colorectal cancer-associated mutations.";
RL   Mol. Cell. Biol. 17:4465-4473(1997).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=9545323; DOI=10.1074/jbc.273.16.9837;
RA   Habraken Y., Sung P., Prakash L., Prakash S.;
RT   "ATP-dependent assembly of a ternary complex consisting of a DNA
RT   mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes.";
RL   J. Biol. Chem. 273:9837-9841(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MLH2; MLH3 AND PMS1.
RX   PubMed=10570173; DOI=10.1073/pnas.96.24.13914;
RA   Wang T.-F., Kleckner N., Hunter N.;
RT   "Functional specificity of MutL homologs in yeast: evidence for three
RT   Mlh1-based heterocomplexes with distinct roles during meiosis in
RT   recombination and mismatch correction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:13914-13919(1999).
RN   [9]
RP   INTERACTION WITH PMS1, ATP-BINDING, AND MUTAGENESIS OF GLU-31 AND
RP   GLY-98.
RX   PubMed=10938116; DOI=10.1128/MCB.20.17.6390-6398.2000;
RA   Tran P.T., Liskay R.M.;
RT   "Functional studies on the candidate ATPase domains of Saccharomyces
RT   cerevisiae MutLalpha.";
RL   Mol. Cell. Biol. 20:6390-6398(2000).
RN   [10]
RP   DNA-BINDING.
RX   PubMed=12222686; DOI=10.1515/BC.2002.103;
RA   Drotschmann K., Hall M.C., Shcherbakova P.V., Wang H., Erie D.A.,
RA   Brownewell F.R., Kool E.T., Kunkel T.A.;
RT   "DNA binding properties of the yeast Msh2-Msh6 and Mlh1-Pms1
RT   heterodimers.";
RL   Biol. Chem. 383:969-975(2002).
RN   [11]
RP   ATP-BINDING, MUTAGENESIS OF GLU-31 AND ASN-35, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=11717305; DOI=10.1074/jbc.M106120200;
RA   Hall M.C., Shcherbakova P.V., Kunkel T.A.;
RT   "Differential ATP binding and intrinsic ATP hydrolysis by amino-
RT   terminal domains of the yeast Mlh1 and Pms1 proteins.";
RL   J. Biol. Chem. 277:3673-3679(2002).
RN   [12]
RP   FUNCTION, AND MUTAGENESIS.
RX   PubMed=12529393; DOI=10.1128/MCB.23.3.873-886.2003;
RA   Argueso J.L., Kijas A.W., Sarin S., Heck J.A., Waase M., Alani E.;
RT   "Systematic mutagenesis of the Saccharomyces cerevisiae MLH1 gene
RT   reveals distinct roles for Mlh1p in meiotic crossing over and in
RT   vegetative and meiotic mismatch repair.";
RL   Mol. Cell. Biol. 23:873-886(2003).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [14]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [15]
RP   DNA-BINDING, AND MUTAGENESIS OF ARG-273 AND ARG-274.
RX   PubMed=12682353; DOI=10.1093/nar/gkg324;
RA   Hall M.C., Shcherbakova P.V., Fortune J.M., Borchers C.H., Dial J.M.,
RA   Tomer K.B., Kunkel T.A.;
RT   "DNA binding by yeast Mlh1 and Pms1: implications for DNA mismatch
RT   repair.";
RL   Nucleic Acids Res. 31:2025-2034(2003).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
CC   -!- FUNCTION: Required for DNA mismatch repair (MMR), correcting base-
CC       base mismatches and insertion-deletion loops (IDLs) resulting from
CC       DNA replication, DNA damage or from recombination events between
CC       non-identical sequences during meiosis. Component of different
CC       MutL heterodimers that form a ternary complex with the MutS
CC       heterodimers, which initially recognize the DNA mismatches. This
CC       complex is thought to be responsible for directing the downsteam
CC       MMR events, including strand discrimination, excision, and
CC       resynthesis. Plays a major role in maintaining the genetic
CC       stability of simple sequence repeats, the repair of heteroduplex
CC       sites present in meiotic recombination intermediates, and the
CC       promotion of meiotic crossing-over. {ECO:0000269|PubMed:10570173,
CC       ECO:0000269|PubMed:12529393, ECO:0000269|PubMed:9545323}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=69 uM for ATP {ECO:0000269|PubMed:11717305};
CC   -!- SUBUNIT: Heterodimer of MLH1 and PMS1, called MutLalpha, which is
CC       the major MMR MutL activity correcting base-base mismatches as
CC       well as IDLs. The heterodimer binds double strand DNA
CC       independently of a mismatch with positive cooperativity and has
CC       more than one DNA binding site. Forms a ternary complex with
CC       either the MSH2-MSH6 (MutSalpha) or the MSH2-MSH3 heterodimer
CC       (MutSbeta), which recognize and bind to mismatch DNA. Ternary
CC       complex formation is promoted by ATP binding. Heterodimer of MLH1
CC       and MLH3, called MutLbeta, which is involved in correction of a
CC       specific subset of IDLs when associated with MutSbeta. Heterodimer
CC       of MLH1 and MLH2. {ECO:0000269|PubMed:9545323}.
CC   -!- INTERACTION:
CC       Q07980:MLH2; NbExp=5; IntAct=EBI-11003, EBI-33369;
CC       Q12083:MLH3; NbExp=4; IntAct=EBI-11003, EBI-31634;
CC       P14242:PMS1; NbExp=7; IntAct=EBI-11003, EBI-13561;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14562095}.
CC   -!- MISCELLANEOUS: Present with 319 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the DNA mismatch repair MutL/HexB family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07187; AAA16835.1; -; Unassigned_DNA.
DR   EMBL; DQ356633; ABC86937.1; -; Genomic_DNA.
DR   EMBL; DQ356634; ABC86938.1; -; Genomic_DNA.
DR   EMBL; DQ356635; ABC86939.1; -; Genomic_DNA.
DR   EMBL; DQ356636; ABC86940.1; -; Genomic_DNA.
DR   EMBL; DQ356637; ABC86941.1; -; Genomic_DNA.
DR   EMBL; DQ356638; ABC86942.1; -; Genomic_DNA.
DR   EMBL; DQ356639; ABC86943.1; -; Genomic_DNA.
DR   EMBL; DQ356640; ABC86944.1; -; Genomic_DNA.
DR   EMBL; DQ356641; ABC86945.1; -; Genomic_DNA.
DR   EMBL; DQ356642; ABC86946.1; -; Genomic_DNA.
DR   EMBL; DQ356643; ABC86947.1; -; Genomic_DNA.
DR   EMBL; DQ356644; ABC86948.1; -; Genomic_DNA.
DR   EMBL; DQ356645; ABC86949.1; -; Genomic_DNA.
DR   EMBL; DQ356646; ABC86950.1; -; Genomic_DNA.
DR   EMBL; Z49705; CAA89803.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10063.1; -; Genomic_DNA.
DR   PIR; S54525; S54525.
DR   RefSeq; NP_013890.1; NM_001182671.1.
DR   PDB; 4E4W; X-ray; 2.50 A; A=485-769.
DR   PDB; 4FMN; X-ray; 2.69 A; A=485-769.
DR   PDB; 4FMO; X-ray; 3.04 A; A=485-769.
DR   PDBsum; 4E4W; -.
DR   PDBsum; 4FMN; -.
DR   PDBsum; 4FMO; -.
DR   ProteinModelPortal; P38920; -.
DR   SMR; P38920; 5-303, 509-769.
DR   BioGrid; 35345; 95.
DR   DIP; DIP-2412N; -.
DR   IntAct; P38920; 7.
DR   MINT; MINT-625234; -.
DR   MaxQB; P38920; -.
DR   EnsemblFungi; YMR167W; YMR167W; YMR167W.
DR   GeneID; 855203; -.
DR   KEGG; sce:YMR167W; -.
DR   CYGD; YMR167w; -.
DR   EuPathDB; FungiDB:YMR167W; -.
DR   SGD; S000004777; MLH1.
DR   GeneTree; ENSGT00800000124177; -.
DR   InParanoid; P38920; -.
DR   KO; K08734; -.
DR   OMA; IATFGFR; -.
DR   OrthoDB; EOG72RN8H; -.
DR   BioCyc; YEAST:G3O-32857-MONOMER; -.
DR   Reactome; REACT_321734; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; REACT_330788; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   NextBio; 978693; -.
DR   PRO; PR:P38920; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   GO; GO:0032389; C:MutLalpha complex; IPI:SGD.
DR   GO; GO:0097587; C:MutLgamma complex; IPI:SGD.
DR   GO; GO:0005524; F:ATP binding; IMP:SGD.
DR   GO; GO:0016887; F:ATPase activity; IDA:SGD.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0000713; P:meiotic heteroduplex formation; IMP:SGD.
DR   GO; GO:0000710; P:meiotic mismatch repair; IMP:SGD.
DR   GO; GO:0006298; P:mismatch repair; IMP:SGD.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; IMP:SGD.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR002099; DNA_mismatch_repair_fam.
DR   InterPro; IPR011186; DNA_mismatch_repair_MLH1/HexB.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF12; PTHR10073:SF12; 1.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   TIGRFAMs; TIGR00585; mutl; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA damage; DNA repair; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    769       DNA mismatch repair protein MLH1.
FT                                /FTId=PRO_0000178008.
FT   REGION        1    335       DNA- and ATP-binding.
FT   REGION      501    756       Interaction with PMS1.
FT   MOD_RES     441    441       Phosphoserine; by ATM or ATR.
FT                                {ECO:0000269|PubMed:18407956}.
FT   VARIANT     240    240       S -> R (in strain: SK1).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     242    242       D -> E (in strain: YJM326 and YJM339).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     271    271       L -> P (in strain: EAY1066, EAY1068, M2-
FT                                8, M7-8, M5-7, SK1, YJM269, YJM280,
FT                                YJM320, YJM326, YJM339 and YJM627).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     309    309       P -> L (in strain: M2-8).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     321    321       E -> D (in strain: EAY1066).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     333    333       E -> K (in strain: SK1).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     375    375       A -> T (in strain: YJM339).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     452    452       S -> G (in strain: EAY1068, M2-8, M7-8,
FT                                M5-7, YJM269 and YJM627).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     465    465       D -> N (in strain: EAY1066 and YJM280).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     470    470       P -> S (in strain: YJM339).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     607    607       L -> F (in strain: EAY1068, M2-8, M7-8,
FT                                M5-7 and YJM627).
FT                                {ECO:0000269|PubMed:16492773}.
FT   VARIANT     678    678       D -> N (in strain: SK1, YJM320 and
FT                                YJM339). {ECO:0000269|PubMed:16492773}.
FT   VARIANT     703    703       P -> L (in strain: SK1, YJM320 and
FT                                YJM339). {ECO:0000269|PubMed:16492773}.
FT   VARIANT     761    761       D -> G (in strain: EAY1066, EAY1068, M2-
FT                                8, M7-8, M5-7, SK1, YJM145, YJM269,
FT                                YJM320, YJM339 and YJM627; forms a non-
FT                                functional heterodimer with PMS1 from
FT                                strain S288c, resulting in an
FT                                accumulation of mutations in spore
FT                                progeny of crosses between these
FT                                strains). {ECO:0000269|PubMed:16492773}.
FT   MUTAGEN      31     31       E->A: Reduces ATPase activity by 98%.
FT                                Displays 3300-fold increase in
FT                                spontaneous mutation accumulation.
FT                                {ECO:0000269|PubMed:10938116,
FT                                ECO:0000269|PubMed:11717305}.
FT   MUTAGEN      35     35       N->A: Abolishes ATP binding, reducing
FT                                ATPase activity by 95%. Displays 9800-
FT                                fold increase in spontaneous mutation
FT                                accumulation.
FT                                {ECO:0000269|PubMed:11717305}.
FT   MUTAGEN      41     41       A->F: Defective in a mismatch repair
FT                                assay. Abolishes heterodimer formation.
FT                                Displays an increases spontaneous
FT                                mutation accumulation.
FT                                {ECO:0000269|PubMed:11555625,
FT                                ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      41     41       A->G: Reduces heterodimer formation.
FT                                Displays an weak increase in spontaneous
FT                                mutation accumulation.
FT                                {ECO:0000269|PubMed:11555625,
FT                                ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      41     41       A->S: Fully functional in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625,
FT                                ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      64     64       G->R: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN      65     65       I->N: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN      96     96       F->A: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      97     97       R->A: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      98     98       G->A: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:10938116,
FT                                ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      98     98       G->V: Abolishes heterodimer formation.
FT                                Displays an increase in spontaneous
FT                                mutation accumulation.
FT                                {ECO:0000269|PubMed:10938116,
FT                                ECO:0000269|PubMed:9234704}.
FT   MUTAGEN      99     99       E->K: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     104    104       I->R: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     114    114       T->R: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     214    214       R->C: Partially defective in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     216    216       V->I: Fully functional in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     265    265       R->C: Partially defective in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     265    265       R->H: Partially defective in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     273    273       R->E: Strongly reduces DNA-binding and
FT                                displays 12000-fold increase in
FT                                spontaneous mutation accumulation; when
FT                                associated with E-274.
FT                                {ECO:0000269|PubMed:12682353}.
FT   MUTAGEN     274    274       R->E: Reduces DNA-binding and displays a
FT                                1700-fold increase in spontaneous
FT                                mutation accumulation. Strongly reduces
FT                                DNA-binding and displays 12000-fold
FT                                increase in spontaneous mutation
FT                                accumulation; when associated with E-273.
FT                                {ECO:0000269|PubMed:12682353}.
FT   MUTAGEN     326    326       I->A: Partially defective in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     326    326       I->V: Fully functional in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     552    552       Q->L: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     672    672       R->P: Defective in a mismatch repair
FT                                assay. {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     694    694       A->T: Fully functional in a mismatch
FT                                repair assay.
FT                                {ECO:0000269|PubMed:11555625}.
FT   MUTAGEN     764    764       K->E: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN     764    764       K->R: No effect.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN     766    766       F->A: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN     767    767       E->D: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN     769    769       C->A: No effect.
FT                                {ECO:0000269|PubMed:9234704}.
FT   MUTAGEN     769    769       C->S: Displays an increase in spontaneous
FT                                mutation accumulation. Does not impair
FT                                heterodimer formation.
FT                                {ECO:0000269|PubMed:9234704}.
FT   CONFLICT    258    258       P -> L (in Ref. 1; AAA16835).
FT                                {ECO:0000305}.
FT   CONFLICT    288    288       N -> F (in Ref. 1; AAA16835).
FT                                {ECO:0000305}.
FT   CONFLICT    708    708       S -> L (in Ref. 1; AAA16835).
FT                                {ECO:0000305}.
FT   HELIX       512    524       {ECO:0000244|PDB:4E4W}.
FT   HELIX       527    534       {ECO:0000244|PDB:4E4W}.
FT   STRAND      537    543       {ECO:0000244|PDB:4E4W}.
FT   TURN        544    547       {ECO:0000244|PDB:4E4W}.
FT   STRAND      548    553       {ECO:0000244|PDB:4E4W}.
FT   STRAND      556    561       {ECO:0000244|PDB:4E4W}.
FT   HELIX       562    577       {ECO:0000244|PDB:4E4W}.
FT   STRAND      582    585       {ECO:0000244|PDB:4E4W}.
FT   HELIX       591    593       {ECO:0000244|PDB:4E4W}.
FT   HELIX       597    601       {ECO:0000244|PDB:4E4W}.
FT   HELIX       610    622       {ECO:0000244|PDB:4E4W}.
FT   HELIX       624    631       {ECO:0000244|PDB:4E4W}.
FT   STRAND      634    639       {ECO:0000244|PDB:4E4W}.
FT   HELIX       644    646       {ECO:0000244|PDB:4E4W}.
FT   STRAND      647    654       {ECO:0000244|PDB:4E4W}.
FT   HELIX       666    675       {ECO:0000244|PDB:4E4W}.
FT   HELIX       682    697       {ECO:0000244|PDB:4E4W}.
FT   HELIX       714    733       {ECO:0000244|PDB:4E4W}.
FT   HELIX       735    742       {ECO:0000244|PDB:4E4W}.
FT   HELIX       747    752       {ECO:0000244|PDB:4E4W}.
FT   STRAND      753    758       {ECO:0000244|PDB:4E4W}.
FT   HELIX       759    765       {ECO:0000244|PDB:4E4W}.
SQ   SEQUENCE   769 AA;  87062 MW;  B2DBB31DE3943171 CRC64;
     MSLRIKALDA SVVNKIAAGE IIISPVNALK EMMENSIDAN ATMIDILVKE GGIKVLQITD
     NGSGINKADL PILCERFTTS KLQKFEDLSQ IQTYGFRGEA LASISHVARV TVTTKVKEDR
     CAWRVSYAEG KMLESPKPVA GKDGTTILVE DLFFNIPSRL RALRSHNDEY SKILDVVGRY
     AIHSKDIGFS CKKFGDSNYS LSVKPSYTVQ DRIRTVFNKS VASNLITFHI SKVEDLNLES
     VDGKVCNLNF ISKKSISPIF FINNRLVTCD LLRRALNSVY SNYLPKGNRP FIYLGIVIDP
     AAVDVNVHPT KREVRFLSQD EIIEKIANQL HAELSAIDTS RTFKASSIST NKPESLIPFN
     DTIESDRNRK SLRQAQVVEN SYTTANSQLR KAKRQENKLV RIDASQAKIT SFLSSSQQFN
     FEGSSTKRQL SEPKVTNVSH SQEAEKLTLN ESEQPRDANT INDNDLKDQP KKKQKLGDYK
     VPSIADDEKN ALPISKDGYI RVPKERVNVN LTSIKKLREK VDDSIHRELT DIFANLNYVG
     VVDEERRLAA IQHDLKLFLI DYGSVCYELF YQIGLTDFAN FGKINLQSTN VSDDIVLYNL
     LSEFDELNDD ASKEKIISKI WDMSSMLNEY YSIELVNDGL DNDLKSVKLK SLPLLLKGYI
     PSLVKLPFFI YRLGKEVDWE DEQECLDGIL REIALLYIPD MVPKVDTSDA SLSEDEKAQF
     INRKEHISSL LEHVLFPCIK RRFLAPRHIL KDVVEIANLP DLYKVFERC
//
